![Christina Bebernitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Dr. Christina E.
Bebernitz is a Research Analyst at First Light Asset Management LLC.
He conducts financial modeling, expert network due diligence, industry and market research, and channel surveillance.
Dr. Bebernitz was previously employed as an Associate by SVB Securities LLC.
Aktive Positionen von Christina Bebernitz
| Unternehmen | Position | Beginn |
|---|---|---|
First Light Asset Management LLC
 First Light Asset Management LLC Investment ManagersFinance First Light manages a long-only health care equity investment strategy (the Genesis Strategy) for separate account clients. The Genesis Strategy utilizes a fundamental, bottom-up approach to stock selection to primarily seek out high quality, reasonably priced, growth-equity opportunities among publicly traded micro to small/mid-cap health care and life sciences companies. | Analyst-Equity | 01.07.2023 |
Ehemalige bekannte Positionen von Christina Bebernitz
| Unternehmen | Position | Ende |
|---|---|---|
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.06.2023 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
First Light Asset Management LLC
First Light Asset Management LLC Investment ManagersFinance First Light manages a long-only health care equity investment strategy (the Genesis Strategy) for separate account clients. The Genesis Strategy utilizes a fundamental, bottom-up approach to stock selection to primarily seek out high quality, reasonably priced, growth-equity opportunities among publicly traded micro to small/mid-cap health care and life sciences companies. | Finance |
